Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction-Reference-Cited by-同舟云学术

Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction

Published:1997-09 Issue:36 Volume:272 Page:22771-22775
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wang Wenfu,Zhou Guisheng,Hu Mickey C.-T.,Yao Zhengbin,Tan Tse-Hua

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference29 articles.

1. Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation

2. Raf meets Ras: completing the framework of a signal transduction pathway

3. A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells

4. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

5. The stress-activated protein kinase subfamily of c-Jun kinases

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress;Expert Opinion on Therapeutic Targets;2024-04-02

2. Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation;International Journal of Molecular Sciences;2023-12-16

3. Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status;Frontiers in Immunology;2023-10-31

4. Construction and Validation of a Prognostic Model Based on Novel Senescence‐Related Genes in Non‐Small Cell Lung Cancer Patients with Drug Sensitivity and Tumor Microenvironment;Advanced Biology;2023-07-30

5. The development of small-molecule inhibitors targeting HPK1;European Journal of Medicinal Chemistry;2022-12